#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15164	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2501	748.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1626	1626	C	871	C,A,T,G	867,2,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15164	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2501	748.3	0	HET	.	.	.	C611T,A,G	.	611	611	C	1053	1053	C	908	C,T,A,G	679,226,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25084	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3996	782.1	0	.	n	.	0	T695C	SNP	695	695	T	1287	1287	C	918	C,T,A	915,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25084	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3996	782.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1929	1929	A	988	A	988	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25084	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3996	782.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2563	2563	C	833	C,G,A	831,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25084	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3996	782.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3189	3189	T	891	T,G,C	889,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25084	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3996	782.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2637	2637	A	761	A,T,G	759,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2344	folP	852	852	100.0	folP.l6.c17.ctg.1	1945	149.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1148	1150	AGC	240;241;242	A,G;G;C	238,2;241;242	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6266	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3776	206.6	1	SNP	p	S91F	0	.	.	271	273	TCC	758	760	TCC	230;231;231	T;C;C,A	230;231;230,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6266	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3776	206.6	1	SNP	p	D95N	0	.	.	283	285	GAC	770	772	GAC	229;230;229	G,T;A;C	228,1;230;229	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6266	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3776	206.6	1	SNP	p	D95G	0	.	.	283	285	GAC	770	772	GAC	229;230;229	G,T;A;C	228,1;230;229	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2124	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1756	151.1	1	SNP	p	G45D	1	.	.	133	135	GAC	724	726	GAC	255;255;256	G;A,C;C	255;254,1;256	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1160	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1386	104.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3386	204.7	1	SNP	p	D86N	0	.	.	256	258	GAC	823	825	GAC	264;264;263	G;A,C;C	264;263,1;263	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3386	204.7	1	SNP	p	S87R	0	.	.	259	261	AGT	826	828	AGT	261;263;263	A;G;T,C	261;263;262,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3386	204.7	1	SNP	p	S87I	0	.	.	259	261	AGT	826	828	AGT	261;263;263	A;G;T,C	261;263;262,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3386	204.7	1	SNP	p	S87W	0	.	.	259	261	AGT	826	828	AGT	261;263;263	A;G;T,C	261;263;262,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3386	204.7	1	SNP	p	S88P	0	.	.	262	264	TCC	829	831	TCC	262;262;260	T,G;C;C	261,1;262;260	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4518	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3069	183.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1771	1773	GGC	282;278;275	G;G;C	282;278;275	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1462	1464	GCA	249;248;245	G;C;A	249;248;245	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1465	1467	ATC	245;246;245	A;T,A,G;C	245;244,1,1;245	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1477	1479	GTG	250;252;250	G,A,C;T;G	248,1,1;252;250	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1477	1479	GTG	250;252;250	G,A,C;T;G	248,1,1;252;250	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1981	1983	ACC	243;244;244	A,G;C;C	242,1;244;244	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2035	2037	GCG	246;242;242	G;C;G,T	246;242;241,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2035	2037	GCG	246;242;242	G;C;G,T	246;242;241,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2158	2160	GGC	217;219;217	G,C;G,T;C,G	216,1;218,1;216,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2167	2169	GGC	214;216;215	G;G;C	214;216;215	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4188	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2833	184.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2185	2187	CCG	209;211;210	C,G;C;G	208,1;211;210	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5662	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3358	209.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1804	1806	CTG	228;228;228	C,G;T;G	227,1;228;228	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3008	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2262	166.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	777	777	C	219	C	219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	593	595	GGA	245;247;247	G,T,C,A;G;A,G	241,1,1,1;246;246,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	V75I	NONSYN	223	225	GTT	674	676	ATT	246;246;246	ATTT,ATT;T,G;T	234,1;244,2;245	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	716	718	AGC	248;248;248	A;G;C	247;248;248	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	V98I	NONSYN	292	294	GTC	743	745	ATC	252;251;252	A,C;T;C	251,1;251;252	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	808	809	CG	222;221	C,A;G,A	221,1;220,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	811	813	CAG	217;214;219	C;A;G,T	217;214;218,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	815	817	AAA	215;214;217	A;A;A	215;214;217	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	878	880	GAA	211;211;210	G,C;A;A	210,1;211;210	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	902	904	GCA	216;221;219	G;C;A	216;221;219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1088	1090	TCA	238;235;234	T,G;C,T;A	237,1;234,1;234	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1208	1210	CAA	209;205;206	C;A;A	209;205;206	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	.	INDELS	760	762	ACA	1212	1216	ATCAA	205;204;204;205;206	A;T;C;A;A	205;204;204;205;206	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	.	INDELS	763	764	TG	1219	1221	AGT	203;204;204	A;G;T	203;204;204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1226	1228	GAT	203;202;203	G;A;T	203;202;203	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1334	1336	AGT	261;259;260	A,C;G;T,G,C	260,1;259;258,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1340	1342	GAC	264;264;267	G;A;C,A	264;264;266,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1343	1345	TAC	268;270;274	T,G;A;C,T	267,1;270;273,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	1	SNP	p	G120K	1	.	.	358	360	AAG	808	810	CGG	222;221;218	C,A;G,A;G	221,1;220,1;218	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	1	SNP	p	D121N	0	.	.	361	363	GAC	811	814	CGC	217;219;216	C;G,T;C	217;218,1;216	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2816	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1746	200.5	1	SNP	p	A121D	1	.	.	361	363	GAC	811	814	CGC	217;219;216	C;G,T;C	217;218,1;216	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9946	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5284	234.6	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2156	2158	AAT	223;223;227	A;A;T	223;223;227	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1374	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1542	111.1	1	SNP	p	V57M	1	.	.	169	171	ATG	712	714	ATG	236;235;236	A;T;G,A	236;235;235,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
